PENG vs Femoral Block for Hip Fracture
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial compares two pain relief methods, the PENG block and the femoral block, for individuals with hip fractures. Researchers aim to determine which block more effectively manages pain, focusing on various fracture types. Participants will receive one of these treatments based on a randomized schedule. This study suits those diagnosed with a hip fracture and willing to receive an analgesic block. As an unphased trial, it offers participants the chance to contribute to valuable research that could enhance pain management for future patients with hip fractures.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. However, if you have a chronic pain diagnosis and are on preoperative opioids, you may not be eligible to participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that both the PENG block and the femoral block safely manage pain in people with hip fractures.
For the PENG block, studies indicate it effectively reduces pain without major side effects. Patients reported less pain 12, 24, and 48 hours after treatment. Evidence also suggests it causes less muscle weakness compared to other pain relief methods.
The femoral block is well-tolerated. Research suggests it is a safe alternative to opioids for pain relief, managing pain effectively without major side effects.
Both treatments have strong evidence supporting their safety for pain relief in hip fracture patients.12345Why are researchers excited about this trial?
Researchers are excited about these treatments because they offer new approaches to pain management for hip fractures. The PENG Block targets specific nerves associated with hip pain more directly than traditional methods, potentially leading to better pain relief and fewer side effects. On the other hand, the Femoral Block is a well-known technique but is being fine-tuned to maximize effectiveness and safety. Both methods aim to improve patient comfort and recovery, offering promising alternatives to current pain management options like systemic opioids or epidural anesthesia.
What evidence suggests that this trial's treatments could be effective for hip fracture pain?
This trial will compare the effectiveness of the femoral block and the PENG (Pericapsular Nerve Group) block for managing pain from hip fractures. Studies have shown that the femoral block safely and effectively reduces pain and limits the need for opioid painkillers, aiding early pain relief and speeding up recovery after surgery. Meanwhile, research indicates that the PENG block controls pain more effectively than other methods and significantly reduces the need for opioids, which can cause unwanted side effects. Both treatments are promising, but the PENG block might offer better overall pain management and fewer complications.13678
Who Is on the Research Team?
Tiffany Tedore, MD
Principal Investigator
Weill Medical College of Cornell University
Are You a Good Fit for This Trial?
Adults aged 18 or older with a diagnosed hip fracture, who consent to pain management via peripheral block and have an ASA Classification of 1-4 (a measure of fitness for anesthesia), can participate. Specific details about the fracture location must be confirmed by radiologic assessment.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either a PENG or femoral block for hip fracture pain based on a randomized monthly schedule
Follow-up
Participants are monitored for pain score changes and opioid consumption for 24 hours post-block
Sub-group Analysis
Analysis to determine differences in efficacy between intracapsular and extracapsular fractures
What Are the Treatments Tested in This Trial?
Interventions
- Femoral Block
- PENG Block
Find a Clinic Near You
Who Is Running the Clinical Trial?
Weill Medical College of Cornell University
Lead Sponsor
New York Presbyterian Hospital
Collaborator